Biomyxib Injection
By Biomyxib
Rx
1 Injection in a Vial

Composition
Colistimethate Sodium(500000IU)

Manufacturer - Health Biotech Limited
S. C. O. 162-164, Indian Airlines Building, Top Floor, Sector 34-A , Chandigarh - 160022, Chandigarh, India

Expires on or after
September, 2025

liver
Safety Advice - Liver Limited information is available regarding the use of Biomyxib Injection in individuals with liver disease. It is essential to inform your doctor of any history of liver impairment or disorders before receiving this injection. Your doctor may need to make adjustments to the dosage or recommend a different treatment option that is more suitable for your condition. It is important to follow your doctor's guidance closely to ensure the safe and effective use of Biomyxib Injection. Please consult with your doctor for proper guidance before using Biomyxib Injection.

kidney
Biomyxib Injection requires caution in patients with kidney disease. Dosage adjustment may be necessary. Inform your doctor if you have severe kidney issues, as they may adjust the dose or suggest an alternative.

alcohol
Limit alcohol intake while using Biomyxib Injection to avoid increased drowsiness, dizziness, or sleepiness. No harmful side effects reported with alcohol consumption.

driving
Caution should be taken when driving after using Biomyxib Injection. It may lower alertness, impact vision, cause drowsiness, or dizziness. Avoid driving if experiencing these effects. Side effects like visual disturbances and dizziness may make driving unsafe; wait until feeling better before driving.

pregnancy
Biomyxib Injection may not be safe during pregnancy. Limited human studies and animal research have shown potential harm to the baby. Inform your doctor if pregnant or suspect pregnancy for a careful assessment of benefits and risks before using.

breastfeeding
Biomyxib Injection may be considered safe during breastfeeding based on limited human data showing no significant risk to the baby. However, it is advised not to use Biomyxib Injection 10 ml in nursing mothers unless necessary. Consult your doctor to assess benefits and potential risks before use.
Habit Forming | No |
Chemical Class | Polypeptides |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Cell membrane active agent |
₹1555
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025